Approach to Myelopathy and Myelitis.
Douglas AG, Xu DJ, Shah MP.
Neurol Clin. 2022 Feb;40(1):133-156. doi: 10.1016/j.ncl.2021.08.009.
Myelopathy.
Ross JS.
Neuroimaging Clin N Am. 1995 Aug;5(3):367-84.
Metabolic and Toxic Myelopathies.
Parks NE.
Continuum (Minneap Minn). 2021 Feb 1;27(1):143-162. doi: 10.1212/CON.0000000000000963.
Metabolic and Toxic Myelopathies.
Slama MCC, Berkowitz AL.
Semin Neurol. 2021 Jun;41(3):309-326. doi: 10.1055/s-0041-1725150. Epub 2021 May 19.
Metabolic and Toxic Myelopathies.
Schwendimann RN.
Continuum (Minneap Minn). 2018 Apr;24(2, Spinal Cord Disorders):427-440. doi: 10.1212/CON.0000000000000596.
AIDS-associated vacuolar myelopathy.
Di Rocco A, Simpson DM.
AIDS Patient Care STDS. 1998 Jun;12(6):457-61. doi: 10.1089/apc.1998.12.457.
Cytoplasmic Localization of HTLV-1 HBZ Protein: A Biomarker of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP).
Baratella M, Forlani G, Raval GU, Tedeschi A, Gout O, Gessain A, Tosi G, Accolla RS.
PLoS Negl Trop Dis. 2017 Jan 17;11(1):e0005285. doi: 10.1371/journal.pntd.0005285. eCollection 2017 Jan.
Metabolic and Toxic Myelopathies.
Holroyd KB, Berkowitz AL.
Continuum (Minneap Minn). 2024 Feb 1;30(1):199-223. doi: 10.1212/CON.0000000000001376.
Hereditary and metabolic myelopathies.
Hedera P.
Handb Clin Neurol. 2016;136:769-85. doi: 10.1016/B978-0-444-53486-6.00038-7.
Autoimmune myelopathies.
Flanagan EP.
Handb Clin Neurol. 2016;133:327-51. doi: 10.1016/B978-0-444-63432-0.00019-0.
